Amphastar Pharmaceuticals (AMPH) Debt Ratio (2013 - 2026)

Amphastar Pharmaceuticals' Debt Ratio history runs 14 years deep, the most recent figure standing at 0.37 for Q1 2026.

• On a quarterly basis, Debt Ratio changed 0.12% year-over-year to 0.37 in Q1 2026; TTM through Mar 2026 was 0.37, a 0.12% change from a year earlier, with the FY2025 full-year figure at 0.37, down 1.81% from the prior year.
• Debt Ratio slipped to 0.37 in Q1 2026 per AMPH's latest filing, from 0.37 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.41 in Q3 2023 and bottomed at 0.1 in Q1 2023.
• The 5-year median for Debt Ratio is 0.37 (2025), against an average of 0.3.
• Across the five-year window, Debt Ratio fell 12.76% in 2022 and jumped 296.95% in 2023, its largest moves.
• Year by year, Debt Ratio stood at 0.1 in 2022, then soared by 281.32% to 0.39 in 2023, then dropped by 2.17% to 0.38 in 2024, then dropped by 1.81% to 0.37 in 2025, then fell by 0.97% to 0.37 in 2026.
• Per Business Quant, the three latest AMPH Debt Ratio figures stand at 0.37 (Q1 2026), 0.37 (Q4 2025), and 0.37 (Q3 2025).